Citation Impact

Citing Papers

Glutamate receptor ion channels
2005 Standout
Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly
1991
Inflammation and Alzheimer's disease
2000 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
Diazepam fails to potentiate GABA-induced chloride uptake and to produce anxiolytic-like action in aged rats
2001
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Soy intake and cancer risk: A review of thein vitroandin vivodata
1994 Standout
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Effects of caffeine on human health
2003 Standout
Sensitivity to Triazolam in the Elderly
1991
Serotonin Syndrome in a Child Associated with Erythromycin and Sertraline
1999
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
2007 Standout
Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
2000
Benzodiazepines and caffeine: effect on daytime sleepiness, performance, and mood
1990
New Hepatocyte In Vitro Systems for Drug Metabolism: Metabolic Capacity and Recommendations for Application in Basic Research and Drug Development, Standard Operation Procedures
2003
Evidence‐based risk factors for postoperative deep vein thrombosis
2004
A Critical Analysis of the Interplay between Cytochrome P450 3A and P-Glycoprotein: Recent Insights from Knockout and Transgenic Mice
2011
Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based Study
2000 Standout
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
2005
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
NMDA receptor hypofunction model of schizophrenia
1999
The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues
2002
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Clinical Pharmacokinetics of Ibuprofen
1998
Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs
1998 Standout
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
2003 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
7-[125I]Iodoclonazepam: Purification by high-performance liquid chromatography for use in a very sensitive benzodiazepine radioimmunoassay of broad specificity
1988
Drug assay using antibody mimics made by molecular imprinting
1993 StandoutNature
The Serotonin Syndrome
2005 Standout
Clinical Pharmacokinetics of Ketoconazole
1988
Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives
2004
Pomegranate Juice Does Not Impair Clearance of Oral or Intravenous Midazolam, a Probe for Cytochrome P450‐3A Activity: Comparison With Grapefruit Juice
2007
Higher Risk of Venous Thrombosis During Early Use of Oral Contraceptives in Women With Inherited Clotting Defects
2000
Prevention of Venous Thromboembolism
2004 Standout
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Capturing complex 3D tissue physiology in vitro
2006 Standout
Problems and Pitfalls in the Use of Benzodiazepines in the Elderly
1990
Prevention of Venous Thromboembolism
2008 Standout
Hippocampal Place Cells Demand Attention
2004 StandoutNobel
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands
1995
Herb-Drug Interactions
2005 Standout
Depressive Signs and Symptoms in Schizophrenia
1998
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects
1992 Standout
Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence
1992 Standout
A Case‐Control Study of Biliary Tract Cancer in Niigata Prefecture, Japan
1989
Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS
1999
In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390
1988 StandoutNobel
Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly
1991
The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation
2016 StandoutNobel
Sleep apnea syndrome and essential hypertension
1985
Maturation of the hemostatic system during childhood
1992 Standout
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
1998
Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health
2011 Standout
Central pre‐ and postsynaptic monoamine receptors in antidepressant therapy
1981
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Phenothiazine and Butyrophenone Intoxication in Children
1986 StandoutNobel
Beta-adrenoceptor antagonists in psychiatry and neurology
1981
Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology
1998
Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?
1986 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
A default mode of brain function
2001 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Problems with current catecholamine hypotheses of antidepressant agents: Speculations leading to a new hypothesis
1983
The Hypercoagulable States
1985
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Pathophysiology of Sleep Apnea
2010 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
The Neuropsychology of Anxiety
2003 Standout
Some current problems related to the mode of action of antidepressant drugs
1981 StandoutNobel
Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents
1979
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
2004
The Neuroleptic Malignant Syndrome
1982
Cimetidine Impairs Clearance of Antipyrine and Desmethyldiazepam in the Elderly
1982
Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (—)-3-PPP
1985 StandoutNobel
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout

Works of Greenblatt Dj being referenced

Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal.
1978
Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials.
1984
Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
2000
On the psychopharmacology of beta adrenergic blockade.
1972
Carbamazepine-induced reduction of plasma alprazolam concentrations: a clinical case report.
1988
Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme.
1973
Spectrophotometric assay of antipyrine in plasma: a reevaluation.
1979
Electron capture GLC analysis of the thienodiazepine clotiazepam. Preliminary pharmacokinetic studies.
1982
Ibuprofen pharmacokinetics: use of liquid chromatography with radial compression separation.
1983
Ketoconazole does not impair antipyrine clearance in humans.
1986
Clinical use of the benzodiazepines.
1981
Effects of diazepam on recall memory: relationship to aging, dose, and duration of treatment.
1989
Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate.
1986
Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo.
1997
Rankless by CCL
2026